176 related articles for article (PubMed ID: 3288989)
1. Malignant transformation by ras and other oncogenes produces common alterations in inositol phospholipid signaling pathways.
Alonso T; Morgan RO; Marvizon JC; Zarbl H; Santos E
Proc Natl Acad Sci U S A; 1988 Jun; 85(12):4271-5. PubMed ID: 3288989
[TBL] [Abstract][Full Text] [Related]
2. Alterations of G-protein coupling function in phosphoinositide signaling pathways of cells transformed by ras and other membrane-associated and cytoplasmic oncogenes.
Alonso T; Srivastava S; Santos E
Mol Cell Biol; 1990 Jun; 10(6):3117-24. PubMed ID: 2160594
[TBL] [Abstract][Full Text] [Related]
3. Growth factors, oncogenes and inositol lipids.
Berridge MJ
Cancer Surv; 1986; 5(2):413-30. PubMed ID: 3779662
[TBL] [Abstract][Full Text] [Related]
4. Role of inositol trisphosphate as a second messenger in signal transduction processes: an essay.
Osborne NN; Tobin AB; Ghazi H
Neurochem Res; 1988 Mar; 13(3):177-91. PubMed ID: 2838762
[TBL] [Abstract][Full Text] [Related]
5. Opposing effects of a ras oncogene on growth factor-stimulated phosphoinositide hydrolysis: desensitization to platelet-derived growth factor and enhanced sensitivity to bradykinin.
Parries G; Hoebel R; Racker E
Proc Natl Acad Sci U S A; 1987 May; 84(9):2648-52. PubMed ID: 2883654
[TBL] [Abstract][Full Text] [Related]
6. Increased intracellular glycerophosphoinositol is a biochemical marker for transformation by membrane-associated and cytoplasmic oncogenes.
Alonso T; Santos E
Biochem Biophys Res Commun; 1990 Aug; 171(1):14-9. PubMed ID: 2393387
[TBL] [Abstract][Full Text] [Related]
7. Normal p21N-ras couples bombesin and other growth factor receptors to inositol phosphate production.
Wakelam MJ; Davies SA; Houslay MD; McKay I; Marshall CJ; Hall A
Nature; 1986 Sep 11-17; 323(6084):173-6. PubMed ID: 3018591
[TBL] [Abstract][Full Text] [Related]
8. NIH-3T3 cells transformed by the EJ-ras oncogene exhibit reduced platelet-derived growth factor-mediated Ca2+ mobilization.
Benjamin CW; Connor JA; Tarpley WG; Gorman RR
Proc Natl Acad Sci U S A; 1988 Jun; 85(12):4345-9. PubMed ID: 3288991
[TBL] [Abstract][Full Text] [Related]
9. Transformation by the k-ras oncogene correlates with increases in phospholipase A2 activity, glycerophosphoinositol production and phosphoinositide synthesis in thyroid cells.
Valitutti S; Cucchi P; Colletta G; Di Filippo C; Corda D
Cell Signal; 1991; 3(4):321-32. PubMed ID: 1657098
[TBL] [Abstract][Full Text] [Related]
10. Identification of the pertussis and cholera toxin substrates in normal and N-ras transformed NIH3T3 fibroblasts and an assessment of their involvement in bombesin-stimulation of inositol phospholipid metabolism.
Milligan G; Davies SA; Houslay MD; Wakelam MJ
Oncogene; 1989 May; 4(5):659-63. PubMed ID: 2498808
[TBL] [Abstract][Full Text] [Related]
11. Desensitization of the Ca2+-mobilizing system to serum growth factors by Ha-ras and v-mos.
Maly K; Doppler W; Oberhuber H; Meusburger H; Hofmann J; Jaggi R; Grunicke HH
Mol Cell Biol; 1988 Oct; 8(10):4212-6. PubMed ID: 3141785
[TBL] [Abstract][Full Text] [Related]
12. Lipid signalling pathways in normal and ras-transfected NIH/3T3 cells.
Matyas GR; Fishman PH
Cell Signal; 1989; 1(4):395-404. PubMed ID: 2561989
[TBL] [Abstract][Full Text] [Related]
13. ras-transformed cells: altered levels of phosphatidylinositol-4,5-bisphosphate and catabolites.
Fleischman LF; Chahwala SB; Cantley L
Science; 1986 Jan; 231(4736):407-10. PubMed ID: 3001936
[TBL] [Abstract][Full Text] [Related]
14. Metabolism and functions of inositol phosphates.
Hughes AR; Putney JW
Biofactors; 1988 Jul; 1(2):117-21. PubMed ID: 3076438
[TBL] [Abstract][Full Text] [Related]
15. Activation of phospholipase D by growth factors and oncogenes in murine fibroblasts follow alternative but cross-talking pathways.
del Peso L; Lucas L; Esteve P; Lacal JC
Biochem J; 1997 Mar; 322 ( Pt 2)(Pt 2):519-28. PubMed ID: 9065772
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of inositol phospholipid metabolism and activation of protein kinase C in ras-transformed rat fibroblasts.
Huang M; Chida K; Kamata N; Nose K; Kato M; Homma Y; Takenawa T; Kuroki T
J Biol Chem; 1988 Dec; 263(34):17975-80. PubMed ID: 3056934
[TBL] [Abstract][Full Text] [Related]
17. Signal transduction in EJ-H-ras-transformed cells: de novo synthesis of diacylglycerol and subversion of agonist-stimulated inositol lipid metabolism.
Chiarugi VP; Magnelli L; Pasquali F; Basi G; Ruggiero M
FEBS Lett; 1989 Jul; 252(1-2):129-34. PubMed ID: 2668028
[TBL] [Abstract][Full Text] [Related]
18. Inositol trisphosphate, a novel second messenger in cellular signal transduction.
Berridge MJ; Irvine RF
Nature; 1984 Nov 22-28; 312(5992):315-21. PubMed ID: 6095092
[TBL] [Abstract][Full Text] [Related]
19. Deregulated expression of interferon regulatory factor-1 in oncogene-transformed mouse fibroblasts.
Contente S; Attard FA; Yeh TJ; Buchhagen DL; Friedman RM
J Interferon Cytokine Res; 2003 Nov; 23(11):639-47. PubMed ID: 14651778
[TBL] [Abstract][Full Text] [Related]
20. Maintenance of PtdIns45P2 pools under limiting inositol conditions, as assessed by liquid chromatography-tandem mass spectrometry and PtdIns45P2 mass evaluation in Ras-transformed cells.
Berrie CP; Dragani LK; van der Kaay J; Iurisci C; Brancaccio A; Rotilio D; Corda D
Eur J Cancer; 2002 Dec; 38(18):2463-75. PubMed ID: 12460792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]